help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, L.
Right arrow Articles by Shipston, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, L.
Right arrow Articles by Shipston, M. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM
*SODIUM
Endocrinology Vol. 141, No. 8 2930-2937
Copyright © 2000 by The Endocrine Society


ARTICLES

Characterization of Hyperpolarization-Activated Cation Currents in Mouse Anterior Pituitary, AtT20 D16:16 Corticotropes1

Lijun Tian and Michael J. Shipston

Membrane Biology Group, Department of Biomedical Sciences, University of Edinburgh Medical School, Edinburgh, Scotland EH8 9AG, United Kingdom

Address all correspondence and requests for reprints to: Michael J. Shipston, Ph.D., Membrane Biology Group, Department of Biomedical Sciences, University of Edinburgh Medical School, Teviot Place, Edinburgh, Scotland EH8 9AG, United Kingdom. E-mail: mike.shipston{at}ed.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The properties of the hyperpolarization-activated inward cation current (Ih) in mouse anterior pituitary, AtT20 D16:16 corticotropes was characterized by whole cell patch clamp recording. In response to hyperpolarizing steps a large, slowly activating, voltage-dependent inward current was activated with a half maximal activation voltage (V0.5) of -96.2 ± 3.1 mV with a time constant of 168 ± 13 msec determined at -140 mV at room temperature. Ih had a reversal potential of -35.5 ± 1.0 mV and -23.3 ± 1.4 mV using 5 mM and 25 mM extracellular K+, respectively, with a relative permeability ratio for Na+ and K+ of 0.24. The current was completely blocked by 2 mM extracellular CsCl and partially blocked by ZD7288 (100 µM) but was unaffected by TEA (10 mM) or Ba2+ (1 mM). RT-PCR analysis revealed robust expression of HCN1, but not HCN2 or HCN3, subunits of hyperpolarization-activated cation channels. The endogenous Ih current was weakly activated by cAMP but robustly inhibited by the cAMP antagonist, Rp-8-CPT-cAMPS. Activation or suppression of protein kinase C activity had no significant effect on the Ih current. The data suggest that in AtT20 D16:16 corticotropes Ih is tonically regulated by the cAMP-signaling cascade and may serve to limit excessive hyperpolarization.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE RELEASE of the stress hormone ACTH is tightly controlled by the interplay between the stimulatory hypothalamic neuropeptides CRH and arginine vasopressin (AVP) and the inhibitory glucocorticoid hormones (1, 2, 3). CRH and AVP, via the cAMP/protein kinase A and phospholipase/protein kinase C pathways respectively, elicit membrane depolarization and enhanced action potential frequency resulting in voltage gated calcium entry and subsequent stimulation of ACTH release (1, 2, 3, 4). Several ion channels have been shown to be targets for CRH and AVP that elicit depolarization or modulate voltage-dependent calcium influx. However, ion channels involved in driving membrane potential from rest to threshold for action potential generation have not been well characterized in corticotropes (4, 5, 6).

In many neurones and other excitable cells, hyperpolarization-activated cation currents (previously termed Ih, If, or Iq) act to depolarize membrane potential to threshold required for action potential generation (for reviews see Refs. 7, 8). Importantly, these currents are targets for regulation by the signal transduction pathways activated by distinct G protein-linked receptors that enhance cellular excitability (8, 9, 10). Furthermore, the ion channel subunits that underlie these currents have recently been cloned [termed HCN 1 to 4: (7, 11, 12, 13)].

Although preliminary studies have suggested that corticotropes express a hyperpolarization-activated cation current whose activation kinetics are accelerated by stimulation of the CRH pathway (14), the properties and regulation of hyperpolarization-activated cation currents have not been defined in anterior pituitary corticotropes.

To examine whether hyperpolarization-activated cation currents play an important role in corticotrope function we have examined the properties, subunit expression, and regulation of the hyperpolarization-activated cation current in mouse anterior pituitary corticotrope, AtT20 D16:16, cells. AtT20 cells have been widely exploited as a model system to explore the regulation of corticotrope function by CRH and cAMP-mediated signal transduction pathways (1, 2, 3, 4). Our data suggest that mouse AtT20 D16:16 corticotropes express HCN 1 channel subunits that give rise to hyperpolarization-activated cation (Ih) currents that are tonically modulated by the cAMP pathway. However, the activation kinetics of the endogenous Ih current, and lack of effect of Ih blockers on resting membrane potential, suggest that Ih does not play a significant pacemaker role in corticotropes, rather may act as a brake of membrane hyperpolarization.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
AtT20 D16:16 cell culture
AtT20 D16:16 cells were subcultured as previously described (15) and used 3–7 days postplating on glass coverslips. Briefly, cells were maintained in DMEM containing 10% FCS (Harlan Seralab, Crawley Down, UK) in a humidified atmosphere of 95% air/5% CO2 at 37 C. Cells were routinely passaged every 7 days using 0.25% trypsin in HBSS containing 0.1% EDTA after reaching 80% confluence.

Electrophysiology
Whole cell currents were recorded in the conventional whole cell mode of the patch clamp technique at room temperature (21–23 C). The bath solution (extracellular) unless otherwise stated in the figure legend contained in mM: 140 NaCl, 5 KCl, 5 MgCl2, 0.1 CaCl2, 10 HEPES, 10 TEA, 1 BaCl2, 20 glucose at pH 7.4 and containing 0.002 tetrodotoxin. The patch pipette (intracellular) contained in mM: 140 KCl, 2 MgCl2, 10 HEPES, 30 Glucose, 5 BAPTA (1,2-bis-o-aminophenoxy)ethane-N,N,N',N'-tetracetic acid, tetrasodium salt), 1 mM ATP pH 7.3 with intracellular free calcium [Ca2+]i buffered to 100 nM. These solutions minimized outward voltage-dependent potassium currents, including A-type currents, and inward calcium and sodium currents as well as inwardly rectifying potassium currents predominant in AtT20 cells (16, 17). Cells were voltage clamped at -40 mV and voltage protocols applied as described in respective figure legends protocol with series resistance compensation of >50%. In some experiments, online leak subtraction was applied using a p/8 protocol. All traces shown in figures are representative nonleak subtracted records. Steady-state hyperpolarization-activated inward currents were stable for >30 min under these recording conditions. The current density (measured as pA/pF) of Ih current showed up to a 3-fold variation between cells. Data presented is from cells that displayed at least 100 pA (measured at -140 mV) of Ih current and normalized to the maximal Ih current for each cell. No significant differences in channel properties or regulation were observed between cells with different Ih current densities (not shown). For current clamp experiments, the extracellular bath solution in mM was: 140 NaCl, 5 KCl, 2 MgCl2, 1 CaCl2, 10 HEPES, 20 glucose at pH 7.4 and containing 0.002 tetrodotoxin.

All data acquisition and voltage protocols were controlled by an Axopatch 200B amplifier and pCLAMP 6 software (Axon Instruments Inc., Foster City, CA). All data were sampled at 5 or 10 kHz and filtered at 2 kHz. Pipettes were manufactured from Garner no. 7052 glass, coated with Sylgard, with resistance’s of 1–3 M{Omega} in physiological saline after fire polishing. Series resistance was < 8 M{Omega} before series resistance compensation.

Data analyses were done using pCLAMP v6.0 (Axon Instruments) and Igor Pro 3.1 (Wavemetrics Inc., Lake Oswego, NY). The steady-state activation curve was determined from the amplitude of tail currents measured immediately after stepping to -140 mV after the respective 1 sec pre-pulse voltage step (-20 to -140 mV) as in Fig. 1AGo. Current amplitude (I, expressed relative to peak value at -140 mV, Imax) was plotted as a function of the pre-pulse hyperpolarizing potential and fitted with a Boltzmann function: I = Imax/(1+ exp(V50 - V)/k), where V50 is the voltage for half maximal activation, V is the activation potential, and k is the slope factor reflecting the voltage dependence of activation. Activation time constants were determined by fitting a single exponential to the rising phase of the inward current.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Voltage dependence of activation of the hyperpolarization-activated current in AtT20 cells. A, Representative recording of an AtT20 cell voltage clamped at -40 mV in the conventional whole-cell patch clamp recording mode as described in Materials and Methods. Cells were stepped to the respective voltage (-20 to -140 mV, in 10 mV steps) for 1 sec followed by a step to -140 mV as indicated in voltage protocol schematic. Note: two points at the peak of the respective capacitance transients have been removed for clarity. B, Steady-state activation curve was determined from the mean ± SEM (n = 9 cells) amplitude of the tail current measured immediately after the voltage step to -140 mV (indicated by arrow). Currents were normalized to the maximal current amplitude and plotted as a function of the preceding membrane potential (-20 to -140mV) after off-line subtraction of leak current. The activation curve was fitted by a Boltzmann function as described in Materials and Methods. C, The mean ± SEM (n = 9 cells) time constant of activation plotted as a function of membrane potential (-100 to -140 mV). The time constant of the rising phase of activation was best fit by a single exponential.

 
The reversal potential of the inward hyperpolarization-activated current under different ionic conditions as in Fig. 2Go was determined from tail current analysis of the I/V relationship of the fully activated current using a subtraction protocol. Currents were either fully activated by stepping to -140 mV (protocol I), or depolarized to -20 mV (protocol II) and then stepped back to different test potentials (-100 to + 40 mV, 20 mV steps). The peak amplitude of tail currents at the respective test potentials using protocol II were subtracted from those obtained using protocol I and I/V relationships constructed. Permeability ratios (pNa/pK) were calculated from the reversal potential in each ionic condition using the Goldmann-Hodgkin-Katz equation.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2. Reversal potential of inward hyperpolarization-activated cation current, Ih.. The reversal potential of the inward hyperpolarization-activated current was determined from tail current analysis of the I/V relationship of the fully activated current using a subtraction protocol. Tail current amplitudes were determined at voltage steps of -100 to + 40 mV (20 mV step, indicated by arrow) either: after fully activating the inward current from -40 to -140 mV for 1 sec (protocol I) or; after a step from -40 to -20 mV for 1 sec (protocol II, inward current not activated). A, Representative traces of currents using protocol I (Ai) and II (Aii) with 25 mM extracellular [K+]. B, I/V relationship for the fully activated inward current obtained by subtracting tail current amplitudes using protocol II from those obtained using protocol I and plotted as a function of membrane potential. I/V relationships were determined at 5 mM (squares) or 25 mM (circles) extracellular [K+]. Mean ± SEM n = 4–5/group.

 
RT-PCR analysis
RT-PCR analysis of hyperpolarization-activated cation channel (HCN) isoforms expressed in AtT20 D16:16 cells utilized primers designed against the previously described mouse brain HCN variants, HCN1–3 (12, 13). Briefly, total cellular RNA from approximately 107 mouse AtT20 D16:16 corticotropes was isolated using standard techniques (18). One microgram of this RNA was used as template in a first strand complementary DNA synthesis directed from an anchored deoxyoligo d(T) primer (5'-TTCTAGAATTCAGCGGCCGC(T)30N1N2), using Superscript II reverse transcriptase (Life Technologies, Inc., Paisley, UK). The resultant cDNA was used in a PCR reaction (25–30 cycles) using Taq (Promega Corp.) or Expand polymerase (Roche Molecular Biochemicals) and products analyzed by agarose gel electrophoresis. Primers used for the PCR indicated in Fig. 4Go were as follows. HCN2 [primers span base pairs 1691–2064 of HCN2 (7, 12, 13)]: forward primer (5'-gAA gAT gTA CTT CAT CCA gCA); reverse primer (5'-CTg gCC AAg CTC TgC CTg). HCN1: [primers span base pairs 587-1067 of HCN1 (7, 12, 13)]: forward primer (5'-gAT TAT CCA TCC gTA CAg T); reverse primer (5'-gAg gTC ATA ggT CAT gTg g). HCN3 [primers span base pairs 1484–1874 of HCN3 (12, 13)]: forward primer (5'-gAA gAT gTA CTT CAT CCA gCA); reverse primer (5'-CTT TCC ACT gAg TCg AgC T). RT-PCR products of the correct size (not shown) were also obtained using the HCN1 primer set spanning residues 1731–2116 of HCN1 (7, 12, 13): forward (5'-gAA AAT gTA TTT CAT CCA gCA C); reverse (5'-gTT gAg ggC TgT CAT TTg Ag).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 4. AtT20 cells express HCN1 channel subunits. A, Representative ethidium bromide stained 0.8% agarose gel of RT-PCR products from AtT20 RNA using primers specific for the previously cloned mouse brain hyperpolarization-activated cation channel subunits HCN 1, 2, or 3 as described in Materials and Methods. A single band corresponding to the expected size of RT-PCR product using the HCN1 primer pair was observed. No products were generated using HCN 2 or 3 primer pairs or with HCN1 primer pairs in the absence of the RT of AtT20 RNA. Molecular size markers (MW) are indicated in kbp.

 
Reagents
Phorbol 12-myristate 13-acetate (PMA) was from Alexis Corp. (UK) Ltd. (Nottingham, UK) and maintained as stock 10 mM solutions in Me2SO at -20 C. The final concentration of DMSO in the bath was < 0.001%, which had no significant effect on currents. BAPTA and Tetrodotoxin were from Calbiochem-Novabiochem (UK) Ltd. (Nottingham, UK). ZD 7288 (4-ethylphentlamino-1,2-dimethyl-6-methylaminopyrimidinium chloride) was from SEMAT Technical UK Ltd. 8-CPT-cAMP and Rp-8-CPT-cAMPS was from BIOLOG Life Science Institute (Bremen, Germany). All other reagents were from Sigma, Poole, Dorset, UK or BDH-Merck, Poole, Dorset, UK). Application of drugs at the respective concentrations given in figure legends was by gravity-driven perfusion or in some instances by direct application of concentrated stock solutions to the bath. For cAMP and AMP studies, the pipette was back-filled with cAMP, or AMP, to allow for stable control recordings before diffusion of adenosine analogues into the cell. The calculated diffusion time was 3–5 min.

Statistics
Data are expressed as means ± SEM. Statistical significance was determined by ANOVA as appropriate. A P value of less than 0.05 was considered to be significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Electrophysiological properties of Ih in AtT20 cells
In conventional whole cell voltage-clamp recordings of AtT20 cells exposed to physiological potassium and sodium gradients, hyperpolarizing voltages elicited a slow inward current, Ih (in the presence of 1 mM extracellular Ba2+ to block inwardly rectifying K channels). This current did not inactivate significantly during hyperpolarization steps of greater than 1 sec (Fig. 1AGo). The amplitude and rate of activation of the inward current increased with hyperpolarization being maximal at -140 mV. The activation of Ih was steeply voltage dependent and was well fitted by a Boltzmann function with a half-maximal voltage of activation (V0.5) of -96.2 ± 3.1 mV (n = 9, Fig. 1BGo). The rate of current activation was well fitted by a single exponential with a time constant of 168 ± 13 ms (n = 9, Fig. 1CGo) at -140 mV.

The ion selectivity of the current was determined from the current/voltage relationship (I/V) of tail currents from the fully activated channel using a subtraction pulse protocol (Fig. 2AGo). The reversal potentials of the subtracted tail currents were -35.5 ± 1.0 mV (n = 4) and -23.3 ± 1.4 mV (n = 5) using 5 mM and 25 mM extracellular K+ respectively (Fig. 2BGo). The corresponding relative permeability ratios for Na+ and K+ (pNa/pK), determined from the Goldmann-Hodgkin-Katz equation, were 0.24 and 0.25 at 5 mM and 25 mM KCl, respectively. The reversal potentials determined from the I/V relationship of the fully activated slowly activating current are significantly more depolarized than would be predicted for a pure K+ conductance. The calculated reversal potential if the slowly activating inward current was entirely carried by K+ would be -78 and -40 mV at 5 and 25 mM extracellular KCl, respectively, suggesting that this current is a mixed cation current.

The slowly activating inward current was reversibly blocked (79.1 ± 6.9%, n = 5) by 2 mM extracellular Cs+ and partially, but irreversibly, blocked (46.6 ± 8.0%, n = 5) by 100 µM ZD 7288 (Fig. 3Go, A and B) an inhibitor of Ih in some, but not all, systems (19, 20). Furthermore, 1 mM extracellular Ba2+ only inhibited the total inward current (including IKIR) by 17 ± 6.3% (n = 4), and the inward current was not blocked by millimolar TEA (not shown). Taken together, the kinetic and pharmacological characteristics of the slowly activating hyperpolarization-activated inward cation current has properties similar to that of the hyperpolarization-activated cation current (Ih) present in many neurones and cardiac cells (8, 12, 13).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 3. Ih is blocked by external Cs+ and ZD 7288. A, Representative currents from a single AtT20 cell voltage clamped in the conventional whole cell configuration before (Control), 10 min after extracellular application of 100 µM ZD 7288 or 2 mM Cs+. Cells were voltage clamped at -40 mV and tail current amplitudes (at -140 mV) determined after full activation to -140 mV for 1s as in Fig. 1Go. B, Inhibition of steady-state current amplitude determined at -140 mV expressed as mean ± SEM percentage inhibition of pretreatment control, n = 4/group. Note: two points at the peak of the respective capacitance transients have been removed for clarity.

 
AtT20 cells express HCN1 subunits
To characterize the hyperpolarization-activated cation channel (HCN) subunits expressed in AtT20 cells, we undertook a RT-PCR screen of AtT20 cell messenger RNA (mRNA) using primers designed against the previously published mouse HCN1–3 subunits (7, 12, 13). AtT20 cells displayed robust expression of the HCN1 [also referred to as HAC2 or mBCNG-1 (7, 12, 13) gene product, Fig. 4Go]. However, RT-PCR products with two independent primer sets failed to amplify HCN2 or HCN3 subunits in this cell line (Fig. 4Go). RT-PCR analysis demonstrated that HCN1 was also expressed in the adult mouse anterior pituitary gland (not shown).

Regulation of Ih by cAMP in AtT20 cells
In many systems, Ih currents are modulated by activation of the cAMP pathway by direct binding to the cyclic nucleotide domain in the HCN subunit itself or via PKA dependent phosphorylation (8, 10, 12, 13, 21). Furthermore, modulation of the cAMP cascade in corticotropes represents one of the major signaling pathways by which neuropeptides regulate corticotrope excitability and hormone secretion (1, 2, 3, 4).

In preliminary experiments, bath application of the cell permeable cAMP analog 8-CPT-cAMP, at concentrations up to 1 mM, had no significant effect on Ih current properties over a time course of 15 min (mean activation at -100 mV was 0.3 ± 4.2%, n = 8). The lack of effect of 8-CPT-cAMP was not a result of low membrane permeability of this analog as 8-CPT-cAMP is effective in other whole-cell assays of ion channel function in this system (17). Higher concentrations of 8-CPT-cAMP were not possible, as 1 mM was the limit of solubility under the recording conditions used for Ih analysis.

However, in four out of five experiments in which 1 mM cAMP was included in the patch pipette, in individual experiments 10 min diffusion of cAMP into the cell resulted in a small, but reproducible, right shift in V0.5 by 2–4 mV compared with the V0.5 determined immediately after establishment of the whole cell configuration. This small current activation was maximal at -100 mV (mean activation 20.3 ± 3.6%, n = 4; at -130 mV activation was 14.2 ± 4.2%, n = 4) but was not associated with a statistically significant increase in current activation kinetics when comparing the control and cAMP-treated groups. To verify that the effect of cAMP was specific for the cyclic nucleotide analog of AMP parallel experiments were performed with 1 mM AMP in the patch pipette. Over the same time course of cAMP action (10 min) AMP had no significant effect on Ih (mean activation at -100 mV was 0.3 ± 5.4%, n = 4).

In contrast, bath application of the cell permeable cAMP analog Rp-8-CPT-cAMPS (1 mM), that blocks cAMP binding to cyclic nucleotide binding domains as well as inhibiting PKA (22), reduced the amplitude of the inward Ih current (Fig. 5AGo). The effect of Rp-8-CPT-cAMP was maintained during continued application of the cAMP analog (not shown). The inhibitory effect of Rp-8-CPT-cAMP was detectable within 1 min of bath application and maximal between 3–5 min. The mean inhibition of the inward current determined at -130 mV was 29.2 ± 4.5% after 10 min (n = 5). This inhibition resulted in a left shift (to more negative potentials) in the V0.5 of current activation by 11 mV (Fig. 5BGo, n = 5) and a significant (P < 0.01, ANOVA, n = 5) slowing of current activation at all potentials examined (Fig. 5CGo). This suggests that at resting free calcium levels, the endogenous Ih current is tonically activated by cAMP, and this can be relieved by the cAMP antagonist Rp-8-CPT-cAMPS. Taken together, these data suggest that the cAMP intracellular signaling pathway tonically regulates the endogenous Ih current in AtT20 cells.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. Regulation of Ih by cAMP in AtT20 cells. A, Representative traces from an AtT20 cell voltage clamped at -40 mV in the conventional whole cell recording configuration before (Control, open square) and 5 min after bath application the cell permeable cAMP antagonist Rp-8-CPT-cAMPS (1 mM, closed square). Inward currents were elicited by stepping to -130 mV for 1 sec and tail current amplitudes determined immediately after the step to -140 mV as indicated by the arrow (as in Fig. 1Go). B, Steady-state activation curve was determined from the mean ± SEM (n = 5 cells/group) amplitude of the tail current measured immediately after the voltage step to -140 mV (indicated by arrow) from different pre-pulse potentials (20 to -140 mV) as described in Fig. 1Go. The activation curve (not shown) for both control (open square) and after Rp-8-CPT-cAMPS application (closed square) was fitted by a Boltzmann function as described in Materials and Methods. C, The mean ± SEM (n = 5 cells/group) time constant of activation plotted as a function of membrane potential (-100 to -140 mV) for control (open square) and Rp-8-CPT-cAMPS (closed square) treated cells. The time constant of the rising phase of activation was best fit by a single exponential.

 
Ih is not regulated by activation of the protein kinase C pathway in AtT20 cells
As activation of the protein kinase C (PKC) pathway represents a major route for regulation of corticotrope function (1, 2, 3, 4, 15), we addressed whether PKC modulated Ih in AtT20 cells. Treatment of AtT20 cells with 100 nM of the protein kinase C activator, PMA, had no significant effect on the activation kinetics, amplitude or V0.5 of the endogenous Ih current compared with pre-treatment control values (Fig. 6Go, A–C). The time constant of activation, determined at -140 mV, was 184.3 ± 11.1 msec (n = 7) in cells treated with PMA for 10 min compared with 189.6 ± 22.3 ms in the corresponding pretreatment controls (Fig. 6CGo, n = 7). The V0.5 was -98.8 ± 3.1 mV (n = 7) and -95.1 ± 2.1 mV (n = 7) in PMA-treated and control cells, respectively (Fig. 6BGo). Furthermore, treatment of cells for > 10 min with the protein kinase C inhibitor bisindolylmaleimide I (100 nM), that blocks PKC activity in this system (15) had no significant effect on the endogenous Ih current (not shown).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 6. Activation of PKC has no effect on Ih in AtT20 cells. A, Representative traces from an AtT20 cell voltage clamped at -40 mV in the conventional whole cell recording configuration before (Control, open square) and 10 min after bath application of a maximally effective (100 nM) concentration of the protein kinase C activator Phorbol 12,13 myristate acetate (PMA, closed square). Inward currents were elicited by stepping to -130 mV for 1 sec and tail current amplitudes determined immediately after the step to -140 mV as indicated by the arrow (as in Fig. 1Go). B, Steady-state activation curve was determined from the mean ± SEM (n = 7 cells/group) amplitude of the tail current measured immediately after the voltage step to -140 mV (indicated by arrow) as described in Fig. 1Go. The activation curve (not shown) for both control (open square) and PMA (closed square) was fitted by a Boltzmann function as described in Materials and Methods. C, Mean ± SEM (n = 7 cells/group) time constant of activation plotted as a function of membrane potential (-100 to -140 mV) for control (open square) and PMA (closed square)-treated cells. The time constant of the rising phase of activation was best fit by a single exponential. Note: two points in the respective capacitance transients have been removed for clarity.

 
Ih acts as a brake of membrane hyperpolarization in AtT20 cells
To address whether the Ih current plays a significant role in the maintenance of the resting membrane potential in AtT20 cells, we undertook current clamp analysis before and after bath application of 100 µM ZD7288 or 2 mM CsCl. In control cells, the mean resting membrane potential was -45.0 ± 2.4 mV (n = 8) and was not significantly affected by 5 min bath application of either ZD7288 (-42.4 ± 2.6 mV, n = 4) or CsCl (-43.8 ± 3.1 mV, n = 4).

To examine whether Ih acts as a brake to excessive hyperpolarization, we examined the membrane potential response to hyperpolarizing current injection before and after complete block of Ih with 2 mM extracellular CsCl (Fig. 7Go). Hyperpolarizing current injection (-40 pA, 1 sec duration) resulted in a transient membrane hyperpolarization that relaxed to a steady-state level in control cells (Fig. 7Go). Bath application of 2 mM CsCl reversibly enhanced the membrane hyperpolarization to the current injection (Fig. 7Go, A and B). The mean steady-state membrane potential determined at 950 ms into the pulse was -70.0 ± 6.5 mV, n = 5 in control and -111.4 ± 10.9 mV, n = 5 after bath application of 2 mM CsCl. This data suggests that Ih acts as a brake on membrane hyperpolarization in AtT20 cells.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 7. Ih serves as a brake of membrane hyperpolarization in AtT20 cells. A, Representative traces from an AtT20 cell under current clamp in the conventional whole-cell recording configuration as described in Materials and Methods. Cells were clamped at 0 pA and the membrane potential response to a hyperpolarizing current injection (-40 pA for 1 sec) determined in control and after complete block of Ih by bath application of 2 mM extracellular CsCl. In this cell the resting membrane potential was -40 mV. B, Mean ± SEM (n = 5 cells/group) steady-state membrane potential response to a 1-sec hyperpolarizing current injection (-40 pA) determined 950 msec into the pulse in control, on extracellular application of 2 mM CsCl and after washout.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this report, we describe the properties and regulation of the endogenous hyperpolarization-activated cation (Ih) current in mouse anterior pituitary corticotropes. Although mouse AtT20 D16:16 corticotropes display robust Ih currents that are modulated by the cAMP pathway, the properties of the Ih current suggests that Ih does not play a significant pacemaker role in mouse corticotropes; rather, it may act as a brake of membrane hyperpolarization. Furthermore, RT-PCR analysis suggests that AtT20 D16:16 corticotropes express HCN1, but not HCN2 or HCN3 channel subunits.

Properties of Ih in AtT20 cells.
The mixed cation hyperpolarization-activated (Ih) inward current in AtT20 D16:16 cells displayed characteristics similar to those described in central neurones, cardiac cells and other endocrine cells termed Ih, If and Iq (for reviews see Refs. 7, 8).

First, the slowly activating voltage-dependent inward currents had half maximal voltage of activation and activation time constant values within the ranges typically reported in other systems and for the cloned mouse HCN2 and HCN1 subunits expressed in HEK 293 cells and Xenopus oocytes, respectively (7, 8, 12, 13). Importantly, the inward currents were robust in ‘physiological’ K+ and Na+ gradients, suggesting they contribute a significant inward current during periods of hyperpolarization.

Second, the weak ionic selectivity of the current for K+ relative to Na+ (relative permeability pNa/pK = 0.24) and sensitivity to millimolar external Cs+, but not Ba2+, support a mixed cation-selective current with pharmacology similar to that observed in native tissues as well as with cloned subunits (8, 12, 13). In contrast to the robust inhibition of Ih by low micromolar concentrations of ZD7288, the Ih current in AtT20 cells was only partially inhibited by ZD7288 concentrations up to 100 µM. ZD7288 is a relatively specific inhibitor of Ih in some, but not all, central neurones (19, 20). However, as the potency of ZD7288 on cloned HCN channels has not been reported, and the subunit composition of Ih channels are largely unknown in native tissue the lack of effect of ZD7288 may reflect the HCN subunits expressed in AtT20 cells. Although ZD7288 did not fully inhibit Ih and CsCl, that fully blocks the current, is nonselective in AtT20 cells (23), neither Ih blocker had any significant effect on the resting membrane potential of AtT20 cells. This suggests that Ih does not play an important role in maintenance of the resting membrane potential, but rather may provide a negative feedback mechanism to factors that induce significant hyperpolarization as suggested for other anterior pituitary cells (24). Indeed, complete blockade of Ih with CsCl resulted in an exaggerated membrane hyperpolarization in response to hyperpolarizing current injection. Such a function is further supported by the observation that the half-maximal voltage required for Ih activation in AtT20 cells is approximately 50 mV more negative than the normal resting potential of these cells.

Third, Ih in AtT20 cells was regulated by modulation of cAMP levels in line with the activation of Ih currents by cAMP either by direct binding to the cyclic nucleotide binding domain in the HCN channel pore-forming subunits or via protein kinase A (11, 12, 13, 21). This suggests that Ih may be an important target for regulators of corticotrope function that modulate intracellular cAMP levels; however, as discussed above, this most likely plays a significant role only during conditions of significant hyperpolarization.

Finally, RT-PCR analysis revealed robust expression of HCN1, but not HCN2 or HCN3, channel subunits suggesting that the endogenous Ih current in AtT20 D16:16 corticotropes is composed of HCN1 [also referred to as HAC2 or mBCNG-1: (7, 11, 12, 13)] subunits.

Regulation of Ih in AtT20 D16:16 corticotropes
The two major stimulatory intracellular signal transduction pathways in anterior pituitary corticotropes are the cAMP and IP3/protein kinase C cascades. As Ih currents in other systems are regulated by activation of these cascades, we addressed whether manipulation of either pathway resulted in modulation of Ih in corticotropes. Intracellular perfusion of cAMP resulted in a small but reproducible enhancement of Ih current with a shift in half activation potential between 2 and 4 mV, a value similar to that observed in hippocampal neurones and for HCN1 subunits expressed in Xenopus oocytes (10, 13). Bath application of the cell permeable cAMP antagonist, Rp-8-CPT-cAMP resulted in a rapid (< 1 min) inhibition of Ih with a left shift of V0.5 by > 10 mV with a corresponding significant slowing of activation. Rp-8-CPT-cAMP antagonizes cAMP binding to cyclic nucleotide binding domains in other cyclic nucleotide regulated ion channels (22) as well as blocking protein kinase A activation. The rapidity of onset of Rp-8-CPT-cAMP action would suggest that a protein phosphorylation dependent mechanism is not involved in the action of cAMP. In further support of a phosphorylation-independent action of cAMP, blockade of serine threonine phosphatase activity by 100 nM okadaic acid had no significant effect on Ih (not shown).

As Rp-8-CPT-cAMP significantly attenuated Ih under basal recording conditions, these data would suggest that Ih is tonically activated by cAMP at near basal intracellular calcium concentrations in corticotropes. Thus agents that elevate (e.g. CRF) or inhibit (e.g. somatostatin) cAMP levels in corticotropes may regulate Ih directly via cAMP. Indeed, preliminary data in rat corticotropes suggests that CRF modulates Ih (14).

Previous studies in anterior pituitary lactotropes and somatotropes suggested that Ih was not activated by cAMP (24). However, no inhibitors of cAMP were used, and intracellular free calcium was buffered to below 10 nM in these latter studies. As anterior pituitary cells express calcium-regulated adenylate cyclases and Ih can be regulated via calcium dependent regulation of adenylate cyclase (9), and hence cAMP levels in central neurones, the regulation of Ih by cAMP in other pituitary cell types cannot be excluded.

Although activation of the protein kinase C pathway has been shown to regulate Ih currents in some systems (8), activation (using maximally effective concentrations of PMA: (15) or inhibition (using maximally effective concentrations of BIS: (15) of protein kinase C activity in AtT20 D16:16 corticotropes had no significant effect on Ih activation. Thus, as for most systems investigated Ih does not appear to be a major target for regulation by the protein kinase C pathway.

Role for Ih in corticotropes
Ih has been proposed to underlie the pacemaker depolarization in pacemaker cells, determine the resting membrane potential in neurones and act as a mechanism to limit hyperpolarization in other systems (8, 24). Ih is unlikely to play a significant role in pacemaker activity or contribute significantly to resting membrane potential in AtT20 corticotropes as the resting membrane potential rarely hyperpolarizes to within the activation range (<-65 mV) required for Ih activation. Thus Ih is unlikely to play a significant role in the depolarizing potentials from rest leading to calcium-dependent action potential generation or play a major role in setting the resting membrane potential. Rather, as proposed for other anterior pituitary cell types, Ih may serve as a brake of excessive hyperpolarization in response to hyperpolarizing stimuli (24). Rat and human corticotropes in primary culture have similar resting membrane potentials to AtT20 corticotropes (4). However, as different HCN subunits can confer distinct activation and regulatory properties to endogenous Ih currents, analysis of HCN subunit expression and Ih properties in rat and human corticotropes is required to determine whether Ih plays a similar role in these systems.


    Acknowledgments
 
We are grateful to the members of the Membrane Biology Group and Dr. Phil Larkman for helpful discussions.


    Footnotes
 
1 This work was generously supported by The Wellcome Trust. Back

Received January 19, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. King MS, Baertschi AJ 1990 The role of intracellular messengers in adrenocorticotropin secretion in vitro. Experientia 46:26–40[CrossRef][Medline]
  2. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7:351–378[Abstract/Free Full Text]
  3. Shipston MJ 1995 Mechanism(s) of early glucocorticoid inhibition of adrenocorticotropin secretion from anterior pituitary corticotropes. Trends Endocrinol Metab 6:261–266[CrossRef][Medline]
  4. Ritchie AK, Kuryshev YA, Childs GV 1996 Corticotropin-releasing hormone and calcium signalling in corticotropes. Trends Endocrinol Metab 7:365–369[CrossRef][Medline]
  5. Kuryshev YA, Haak L, Childs GV, Ritchie AK 1997 Corticotropin releasing hormone inhibits an inwardly rectifying potassium current in rat corticotropes. J Physiol 502:265–279[Abstract/Free Full Text]
  6. Lee AK, Tse A 1997 Mechanism underlying corticotropin-releasing hormone (CRH) triggered cytosolic Ca2+ rise in identified rat corticotrophs. J Physiol 504:367–378[Abstract/Free Full Text]
  7. Biel M, Ludwig A, Zong X, Hofmann F 1999 Hyperpolarization-activated cation channels: a multi-gene family. Rev Physiol Biochem Pharmacol 136:165–181[Medline]
  8. Pape H 1996 Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu Rev Physiol 58:299–327[CrossRef][Medline]
  9. Luthi A, McCormick D 1999 Modulation of a pacemaker current through Ca2+-induced stimulation of cAMP production. Nature Neurosci 2:634–641[CrossRef][Medline]
  10. Pedarzani P, Storm J 1995 Protein kinase A-independent modulation of ion channels in the brain by cyclic AMP. Proc Natl Acad Sci USA 92:11716–11720[Abstract/Free Full Text]
  11. Ishii T, Takano M, Xie L, Noma A, Ohmori H 1999 Molecular characterization of the hyperpolarization-activated cation channel in rabbit heart sinoatrial node. J Biol Chem 274:12835–12839[Abstract/Free Full Text]
  12. Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M 1998 A family of hyperpolarization-activated mammalian cation channels. Nature 393:587–591[CrossRef][Medline]
  13. Santoro B, Liu DT, Yao H, Bartsch D, Kandel ER, Siegelbaum SA, Tibbs GR 1998 Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 93:717–729[CrossRef][Medline]
  14. Kuryshev Y, Childs G, Ritchie A 1996 Corticotropin releasing hormone modulation of a hyperpolarization-activated current (Ih). Soc Neurosci Abstr 22:1249
  15. Tian L, Philp JA, Shipston MJ 1999 Glucocorticoid block of protein kinase C signalling in mouse pituitary corticotroph AtT20 D16:16 cells. J Physiol 516:757–768[Abstract/Free Full Text]
  16. Surprenant A, Horstman D, Akbarali H, Limbird L 1992 A point mutation of the {alpha}2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 257:977–980[Abstract/Free Full Text]
  17. Shipston MJ, Kelly JS, Antoni FA 1996 Glucocorticoids block protein kinase A inhibition of calcium-activated potassium channels. J Biol Chem 271:9197–9200[Abstract/Free Full Text]
  18. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159[Medline]
  19. BoSmith R, Briggs I, Sturgess N 1993 Inhibitory actions of ZENECA ZD7288 on whole-cell hyperpolarization activated inward current (If) in guinea-pig dissociated sinoatrial node cells. Br J Pharmacol 110:343–349[Medline]
  20. Harris N, Constanti A 1995 Mechanism of block of ZD 7288 of the hyperpolarization-activated inward rectifying current in guinea pig substantia nigra neurons in vitro. J Neurophysiol 74:2366–2378[Abstract/Free Full Text]
  21. Tokimasa T, Akasu T 1990 Cyclic AMP regulates an inward rectifying sodium-potassium current in dissociated bull-frog sympathetic neurones. J Physiol 420:409–429[Abstract/Free Full Text]
  22. Kramer R, Tibbs G 1996 Antagonists of cyclic nucleotide-gated channels and molecular mapping of their site of action. J Neurosci 16:1285–1293[Abstract/Free Full Text]
  23. Pennefather P, Heisler S, MacDonald J 1988 A potassium conductance contributes to the action of somatostatin-14 to suppress ACTH secretion. Brain Res 444:346–350[CrossRef][Medline]
  24. Simasko SM, Sankaranarayanan S 1997 Characterization of a hyperpolarization-activated cation current in rat pituitary cells. Am J Physiol 272:E405–E414



This article has been cited by other articles:


Home page
J EndocrinolHome page
Y. Zhang, Y. Liu, J. Qu, A. Hardy, N. Zhang, J. Diao, P. J Strijbos, R. Tsushima, R. B Robinson, H. Y Gaisano, et al.
Functional characterization of hyperpolarization-activated cyclic nucleotide-gated channels in rat pancreatic {beta} cells
J. Endocrinol., October 1, 2009; 203(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. J. Bolivar, D. Tapia, G. Arenas, M. Castanon-Arreola, H. Torres, and E. Galarraga
A hyperpolarization-activated, cyclic nucleotide-gated, (Ih-like) cationic current and HCN gene expression in renal inner medullary collecting duct cells
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C893 - C906.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. E. Gonzalez-Iglesias, Y. Jiang, M. Tomic, K. Kretschmannova, S. A. Andric, H. Zemkova, and S. S. Stojilkovic
Dependence of Electrical Activity and Calcium Influx-Controlled Prolactin Release on Adenylyl Cyclase Signaling Pathway in Pituitary Lactotrophs
Mol. Endocrinol., September 1, 2006; 20(9): 2231 - 2246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. A. Greenwood and S. A. Prestwich
Characteristics of hyperpolarization-activated cation currents in portal vein smooth muscle cells
Am J Physiol Cell Physiol, April 1, 2002; 282(4): C744 - C753.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, L.
Right arrow Articles by Shipston, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, L.
Right arrow Articles by Shipston, M. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM
*SODIUM


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals